SCHEMBL19752352

SCHEMBL19752352

O=C1CCC(N2Cc3cc(CNC(=O)c4ccc(Cl)c(OCCN5CCOCC5)c4)ccc3C2=O)C(O)N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSPT1 P15170 3/20 0.42
CRBN Q96SW2 3/20 0.42
DDB1 Q16531 2/20 0.42
IKZF3 Q9UKT9 1/20 0.42
UTS2R Q9UKP6 1/20 0.41
CYP2C19 P33261 1/20 0.39
KCNH2 Q12809 1/20 0.39
ROCK2 O75116 1/20 0.39
ROCK1 Q13464 1/20 0.39
KDM1A O60341 1/20 0.39
HDAC1 Q13547 1/20 0.39
SLC5A7 Q9GZV3 1/20 0.38
TSHR P16473 1/20 0.38
KDR P35968 1/20 0.38
FLT3 P36888 1/20 0.38
TNF P01375 1/20 0.37
KMT2A Q03164 1/20 0.37
HTR7 P34969 1/20 0.37
MAPK14 Q16539 1/20 0.36
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70133 0.88 CRBN (0.56) GSPT1CRBNDDB1IKZF3CYP2C19
SCHEMBL68778 0.82 CRBN (0.56) GSPT1CRBNDDB1IKZF3UTS2R
SCHEMBL18402521 0.81 ROCK1 (0.44) GSPT1CRBNDDB1IKZF3CYP2C19
SCHEMBL62041 0.80 CRBN (0.58) GSPT1CRBNDDB1IKZF3CYP2C19
SCHEMBL20470581 0.78 DDB1 (0.50) GSPT1CRBNDDB1IKZF3CYP2C19
SCHEMBL24113860 0.78 UTS2R (0.42) GSPT1CRBNDDB1IKZF3UTS2R
SCHEMBL68285 0.78 CRBN (0.56) GSPT1CRBNDDB1IKZF3CYP2C19
SCHEMBL60346 0.78 CRBN (0.56) GSPT1CRBNDDB1IKZF3CYP2C19
SCHEMBL21863913 0.78 ROCK2 (0.42) GSPT1CRBNDDB1IKZF3UTS2R
SCHEMBL69209 0.78 TNF (0.58) GSPT1CRBNDDB1IKZF3CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2985281-B1 ISOINDOLINE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER CELGENE CORP (US) 2017-12-27 EP disclosed